The Industry Committee oversees the strategies and activities related to the industry and biotech members of the society. The committee aims to create networking, education and collaboration opportunities by providing a forum for those in industry to meet and discuss areas of interest that are particular to those involved in drug development and taking a product to market.
Adrian Bot, MD, PhD – Kite, A Gilead Company
Alessandra Cesano, MD, PhD – NanoString, Inc.
Daniel S. Chen, MD, PhD – Genentech/Roche
Salil Patel, PhD – Bristol-Myers Squibb